FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225395047> ?p ?o ?g. }

• W4225395047 endingPage "733" @default.
• W4225395047 startingPage "722" @default.
• W4225395047 abstract "Abstract Diffuse large B‐cell lymphoma (DLBCL), the most frequent non‐Hodgkin's lymphoma subtype, is characterized by strong biological, morphological, and clinical heterogeneity, but patients are treated with immunochemotherapy in a relatively homogeneous way. Here, we have used a customized NanoString platform to analyze a series of 197 homogeneously treated DLBCL cases. The platform includes the most relevant genes or signatures known to be useful for predicting response to R‐CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) in DLBCL cases. We generated a risk score that combines the International Prognostic Index with cell of origin and double expression of MYC/BCL2 , and stratified the series into three groups, yielding hazard ratios from 0.15 to 5.49 for overall survival, and from 0.17 to 5.04 for progression‐free survival. Group differences were highly significant ( p < 0.0001), and the scoring system was applicable to younger patients (<60 years of age) and patients with advanced or localized stages of the disease. Results were validated in an independent dataset from 166 DLBCL patients treated in two distinct clinical trials. This risk score combines clinical and biological data in a model that can be used to integrate biological variables into the prognostic models for DLBCL cases." @default.
• W4225395047 created "2022-05-05" @default.
• W4225395047 creator A5002306207 @default.
• W4225395047 creator A5003035727 @default.
• W4225395047 creator A5003161551 @default.
• W4225395047 creator A5010578479 @default.
• W4225395047 creator A5011943310 @default.
• W4225395047 creator A5014545445 @default.
• W4225395047 creator A5015180886 @default.
• W4225395047 creator A5018014202 @default.
• W4225395047 creator A5018046514 @default.
• W4225395047 creator A5021107350 @default.
• W4225395047 creator A5027763330 @default.
• W4225395047 creator A5037385421 @default.
• W4225395047 creator A5039397983 @default.
• W4225395047 creator A5040534467 @default.
• W4225395047 creator A5043024390 @default.
• W4225395047 creator A5043985252 @default.
• W4225395047 creator A5043996769 @default.
• W4225395047 creator A5046126884 @default.
• W4225395047 creator A5047736157 @default.
• W4225395047 creator A5048566051 @default.
• W4225395047 creator A5052609166 @default.
• W4225395047 creator A5056332232 @default.
• W4225395047 creator A5060668905 @default.
• W4225395047 creator A5061062098 @default.
• W4225395047 creator A5069047495 @default.
• W4225395047 creator A5069484088 @default.
• W4225395047 creator A5070411650 @default.
• W4225395047 creator A5074244429 @default.
• W4225395047 creator A5077730260 @default.
• W4225395047 creator A5080781872 @default.
• W4225395047 creator A5080872994 @default.
• W4225395047 creator A5084887625 @default.
• W4225395047 creator A5085499011 @default.
• W4225395047 creator A5088750464 @default.
• W4225395047 creator A5091807863 @default.
• W4225395047 date "2022-05-03" @default.
• W4225395047 modified "2023-10-01" @default.
• W4225395047 title "An integrated prognostic model for diffuse large B‐cell lymphoma treated with immunochemotherapy" @default.
• W4225395047 cites W1907582144 @default.
• W4225395047 cites W1976564639 @default.
• W4225395047 cites W1993577803 @default.
• W4225395047 cites W1998275293 @default.
• W4225395047 cites W1999021691 @default.
• W4225395047 cites W2006070956 @default.
• W4225395047 cites W2009002059 @default.
• W4225395047 cites W2022013393 @default.
• W4225395047 cites W2030105242 @default.
• W4225395047 cites W2031322795 @default.
• W4225395047 cites W2034881106 @default.
• W4225395047 cites W2037904581 @default.
• W4225395047 cites W2056641238 @default.
• W4225395047 cites W2068343048 @default.
• W4225395047 cites W2100306945 @default.
• W4225395047 cites W2129272684 @default.
• W4225395047 cites W2136268782 @default.
• W4225395047 cites W2139954541 @default.
• W4225395047 cites W2140485109 @default.
• W4225395047 cites W2142814377 @default.
• W4225395047 cites W2147246240 @default.
• W4225395047 cites W2152640999 @default.
• W4225395047 cites W2158267770 @default.
• W4225395047 cites W2159862107 @default.
• W4225395047 cites W2160881152 @default.
• W4225395047 cites W2178535468 @default.
• W4225395047 cites W2280269954 @default.
• W4225395047 cites W2284991592 @default.
• W4225395047 cites W2310716991 @default.
• W4225395047 cites W2332287549 @default.
• W4225395047 cites W2339030197 @default.
• W4225395047 cites W2528108577 @default.
• W4225395047 cites W2557249738 @default.
• W4225395047 cites W2600992641 @default.
• W4225395047 cites W2614435853 @default.
• W4225395047 cites W2724409437 @default.
• W4225395047 cites W2788380546 @default.
• W4225395047 cites W2797584152 @default.
• W4225395047 cites W2801763724 @default.
• W4225395047 cites W2885252913 @default.
• W4225395047 cites W2897301108 @default.
• W4225395047 cites W2902375153 @default.
• W4225395047 cites W2903278833 @default.
• W4225395047 cites W2923453543 @default.
• W4225395047 cites W2928384177 @default.
• W4225395047 cites W2946060264 @default.
• W4225395047 cites W2961112061 @default.
• W4225395047 cites W2972566401 @default.
• W4225395047 cites W2979378728 @default.
• W4225395047 cites W2982663851 @default.
• W4225395047 cites W2999399899 @default.
• W4225395047 cites W3006338105 @default.
• W4225395047 cites W3007610566 @default.
• W4225395047 cites W3049476531 @default.
• W4225395047 cites W3096550948 @default.
• W4225395047 cites W3196271318 @default.
• W4225395047 cites W4205736005 @default.
• W4225395047 doi "https://doi.org/10.1002/jha2.457" @default.

• next